Onconetix, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
ONCO on Nasdaq
Location
201 E. Fifth Street, Suite 1900, Cincinnati, Ohio

There are no Buy or Sell transactions made by insiders since 8/27/2023

Onconetix, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joseph Hernandez CEO, Director, 10%+ Owner $11.5M May 9, 2023
Cincinnati Cornerstone Investors BWV I, LLC 10%+ Owner $4.76M Apr 10, 2023
Ralph Schiess Chief Science Officer $1.11M Dec 15, 2023
Christian Bruhlmann Chief Strategy Officer $969K Dec 15, 2023
Erin Henderson Chief Business Officer $717K May 9, 2023
Jon Garfield Chief Financial Officer $410K May 9, 2023
Simon Tarsh Director $26.1K May 31, 2023
James Sapirstein Director $26.1K May 31, 2023
Vuk Jeremic Director $26.1K May 31, 2023
Timothy Ramdeen Director $26.1K May 31, 2023
Neil Campbell Chief Executive Officer, Director Oct 4, 2023
Bruce Harmon Chief Financial Officer Oct 4, 2023
Allan Shaw Director Aug 19, 2022
Kimberly Murphy Director May 4, 2022
John McCune Rice Jr. Director Feb 17, 2022
Michael Venerable Director May 4, 2022
Karina M. Fedasz Interim CFO Jun 10, 2024
Ajit Singh Director Feb 16, 2024
Thomas Meier Director Feb 6, 2024

Recent Insider Transactions by Companies or Individuals for Onconetix, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.